Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332
Price:
24.98
CNY
-1.11%
Market Cap:
¥40.2B
Relative Value
The Relative Value of one
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
stock under the Base Case scenario is
hidden
CNY.
Compared to the current market price of 24.98 CNY,
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Competitors
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332
|
40.6B CNY | 0.5 | 13.6 | 11.6 | 11.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
952.4B USD | 14.6 | 46.1 | 31.1 | 33.2 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
592.2B USD | 6.3 | 22.1 | 15.3 | 18.8 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
286.2B CHF | 4.7 | 30.4 | 12.8 | 15 | |
| CH |
|
Novartis AG
SIX:NOVN
|
244.8B CHF | 5.6 | 22.5 | 13.9 | 17.9 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
234.4B GBP | 5.4 | 30.7 | 17 | 23.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
298.8B USD | 4.6 | 16.4 | 10.1 | 12.4 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.5 | 10.6 | 7.9 | 9.2 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
151.6B USD | 2.4 | 19.5 | 7.5 | 10 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.8B USD | 2.6 | 17.8 | 7.4 | 9.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
